Explore professionally built ETF model portfolios. Discover now →

Segment| Data as of 09/04/2026
trending down

BioTech & Genomics ETFs

1D perf
-0.51%
1D flows
-$13M
Total AuM
$2.82B
Total ETFs
7

Aggregate data of 7 funds

Performance

05101520%Aug 4Aug 11Aug 18Aug 25Sep 1

Flows

-100 M0 M100 M200 M300 M
1M3MYTD1Y3Y5Y
Perf.+17.66%+36.20%+54.01%+81.69%+53.20%
Flows+$186M+$403M+$334M+$325M-$389M-

Top ETFs in this segment

1D-1.12%1W flows+$21MView
1D-0.26%1W flows+$7MView
1D-1.08%1W flows+$4MView

Just published in BioTech & Genomics

View all articles

Are Biotechnology ETFs In the Midst of a Comeback?

Biotech stocks are under pressure in 2025, but these ETFs may offer turnaround potential.

Biotech ETFs

Movers in BioTech & Genomics

Top
Bottom
Top performers, 1 week1W perf.YTD perf.
IDNA
iShares Genomics Immunology and Healthcare ETF+1.32%+52.43%
PBE
Invesco Dynamic Biotechnology & Genome ETF+1.29%+20.19%
GNMX
Corgi Genomics & Precision Medicine ETF+0.30% 
WDNA
WisdomTree BioRevolution Fund-0.34%+36.11%
HELX
Franklin Genomic Advancements ETF-0.51%+15.45%
Top inflows, 1 week1W flowYTD flows
PBE
Invesco Dynamic Biotechnology & Genome ETF+$21M+$114M
ARKG
ARK Genomic Revolution ETF+$7M+$141M
IDNA
iShares Genomics Immunology and Healthcare ETF+$4M+$56M
GNMX
Corgi Genomics & Precision Medicine ETF+$704K-
WDNA
WisdomTree BioRevolution Fund+$462K+$105K

Data period: August 28 - September 4, 2026

Performance lists exclude leveraged and inverse ETFs

Recently launched ETFs

Inception

Screener search:

BioTech & Genomics ETFs

Related indexes by ICE

ICEBIO
ICE Biotechnology IndexView on ICE
BTK
NYSE Arca Biotechnology IndexView on ICE
NYFSGIB
NYSE FactSet Global Genomics and Immuno Biopharma IndexView on ICE

Latest news about Thematic Investing: BioTech & Genomics

Are Biotechnology ETFs In the Midst of a Comeback?

Biotech stocks are under pressure in 2025, but these ETFs may offer turnaround potential.

Biotech ETFs

Biotech ETFs – Investing in Health Innovation

With biotech ETFs investors may be able to diversify and gain exposure to biotech companies with less risk and smoother long-term returns.

Biotech ETFs – Investing in Health Innovation
Justin Ho - Writer for NYSE ETF Central
By Justin Ho · July 21, 2022
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides

Recent educational content

Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs August 31, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 1, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs August 24, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · August 24, 2026
What's the Fund | Ocean Park Diversified Income ETF (DUKZ)

What’sTheFund

What's the Fund | Ocean Park Diversified Income ETF (DUKZ)

James St Aubin, Chief Investment Officer at Ocean Park Asset Management, discuss the DUKZ ETF, exposing investors to the whole spectrum of asset classes in the fixed income markets, through their rules-based process.

NYSE logo
By NYSE · August 18, 2026
ETF Takeaway: Ocean Park Diversified Income ETF (DUKZ)

ETF Takeaway

ETF Takeaway: Ocean Park Diversified Income ETF (DUKZ)

James St Aubin, Chief Investment Officer at Ocean Park Asset Management discusses the state of fixed income markets and how their DUKZ ETF, through their rules-based process, tactically allocates to 11 sectors of fixed income through underlying ETFs.

NYSE logo
By NYSE · August 18, 2026

Browse all educational columns

ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder